Related Experiment Video
Updated: Jul 29, 2025

08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
Published on: August 11, 2015
14.0K
Botulinum Toxin Treatment for Depression: A New Paradigm for Psychiatry
Eric Finzi1,2
1Healis Therapeutics, 4041 MacArthur Blvd Suite 400, Newport Beach, CA 92660, USA.
Toxins
|May 26, 2023
Summary
Botulinum toxin A injections into frown muscles show antidepressant effects. This treatment targets facial muscles linked to emotional processing and amygdala activity, offering a novel therapeutic approach.
Area of Science:
- Neuroscience
- Psychiatry
- Dermatology
Background:
- Randomized trials indicate botulinum toxin A (BoNT/A) has antidepressant properties.
- Facial expression muscles play a key role in emotional signaling to the brain.
- Frown musculature acts as a transmitter of negative emotional information.
Purpose of the Study:
- To review the conceptual basis for using BoNT/A as an antidepressant.
- To explore the neuroanatomical pathways involved in facial emotional signaling.
- To discuss the mechanistic link between BoNT/A, amygdala activity, and antidepressant effects.
Main Methods:
- Review of existing randomized double-blind placebo-controlled trials.
- Analysis of evolutionary theory and emotional proprioception concepts.
- Examination of neuroanatomical connections between facial muscles and the amygdala.
Main Results:
- BoNT/A treatment of frown muscles demonstrates antidepressant effects.
- Direct connections exist between corrugator muscles and the amygdala.
- BoNT/A modulates amygdala activity, explaining its antidepressant action.
Conclusions:
- BoNT/A offers a potential treatment for psychiatric disorders by targeting emotional circuits.
- The therapy has a favorable administration profile and side effect profile compared to existing treatments.
- Evidence supports the evolutionary conservation of the emotional circuit targeted by BoNT/A.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
285
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
285
Electroconvulsive Therapy
86
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
86
Antidepressant Drugs: Overview
614
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
614
Drug Therapy
75
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
75
Depression: Overview
294
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
294
Treatment Strategies for Psychological Disorders
195
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
195

